awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28541231-CE1F2098-B329-4155-891B-668DF95522AB
Q28541231-CE1F2098-B329-4155-891B-668DF95522AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28541231-CE1F2098-B329-4155-891B-668DF95522AB
Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use
P2860
Q28541231-CE1F2098-B329-4155-891B-668DF95522AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28541231-CE1F2098-B329-4155-891B-668DF95522AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
07bc4a74b5afdc49390fb7017bb91a71b1ee8d53
P2860
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions